Home / GRM8 Knockout Cell Lines

GRM8 Knockout Cell Lines

Gene: GRM8

Official Full Name: glutamate metabotropic receptor 8provided by HGNC

Gene Summary: L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO07710 GRM8 Knockout cell line (HEK293) Human GRM8 1:3~1:6 Negative Online Inquiry

Background

GRM8 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the functional GRM8 gene, which encodes for the metabotropic glutamate receptor 8. These cell lines serve as invaluable tools for researchers studying the role of GRM8 in various physiological and pathological processes. By providing a model in which the receptor is absent, scientists can elucidate its contributions to neurological functions, synaptic plasticity, and potential implications in disorders such as anxiety, depression, and other neuropsychiatric conditions.

The key function of GRM8 Gene Knockout Cell Lines lies in their ability to facilitate the investigation of receptor-mediated signaling pathways without the interference of GRM8 activity. This is achieved through advanced CRISPR-Cas9 gene-editing technology, which ensures precise and efficient disruption of the gene. Researchers can employ these cell lines in functional assays to analyze downstream effects, assess drug interactions, and explore compensatory mechanisms in cellular pathways.

The scientific importance of these knockout cell lines extends to both basic and translational research. In a clinical context, they offer the potential to drive drug discovery by providing a system to identify novel therapeutics targeting glutamatergic signaling. The insights gained from studies utilizing GRM8 knockouts can pave the way for therapeutic strategies aimed at disorders characterized by dysregulated glutamate signaling.

Compared to alternative models, GRM8 Gene Knockout Cell Lines offer a high level of specificity and reliability. Unlike traditional pharmacological approaches that may yield off-target effects, these genetically modified lines provide researchers with a clean genetic background, ensuring that findings are directly linked to the absence of GRM8 instead of confounding factors.

For researchers, clinicians, and drug developers, the ability to study the role of GRM8 in an unambiguous manner is invaluable, empowering them to uncover the nuances of this receptor's function. Our company specializes in providing high-quality biological products, and we are committed to advancing scientific discovery by equipping the research community with innovative tools such as the GRM8 Gene Knockout Cell Lines.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.